[Federal Register Volume 72, Number 36 (Friday, February 23, 2007)]
[Notices]
[Page 8166]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-3102]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panels (SEP): The Small Business Innovation Research (SBIR) 
020, ``New Laboratory Tests for Tuberculosis and Detection of Drug 
Resistance'' and SRIB 021, ``Development of Novel Information System 
for Remote Tuberculosis Control and Prevention''

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Times and Dates: 1 p.m.-2 p.m., March 30, 2007 (Closed). 2 p.m.-
4 p.m., March 30, 2007 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to 
The Small Business Innovation Research (SBIR) 020, ``New Laboratory 
Tests for Tuberculosis and Detection of Drug Resistance'' and SRIB 
021, ``Development of Novel Information System for Remote 
Tuberculosis Control and Prevention.''
    Contact Person for More Information: J. Felix Rogers, PhD, 
M.P.H., Scientific Review Administrator, Coordinating Center for 
Infectious Diseases, National Center for Immunization and 
Respiratory Diseases, Office of the Director, CDC, 1600 Clifton Road 
NE., Mailstop E05, Atlanta, GA 30333, Telephone 404.639.6101.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: February 15, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. E7-3102 Filed 2-22-07; 8:45 am]
BILLING CODE 4163-18-P